JNK signaling in apoptosis DN Dhanasekaran, EP Reddy Oncogene 27 (48), 6245-6251, 2008 | 1731 | 2008 |
G protein regulation of MAPK networks ZG Goldsmith, DN Dhanasekaran Oncogene 26 (22), 3122-3142, 2007 | 545 | 2007 |
Scaffold proteins of MAP-kinase modules DN Dhanasekaran, K Kashef, CM Lee, H Xu, EP Reddy Oncogene 26 (22), 3185-3202, 2007 | 367 | 2007 |
JNK-signaling: A multiplexing hub in programmed cell death DN Dhanasekaran, EP Reddy Genes & cancer 8 (9-10), 682, 2017 | 320 | 2017 |
MAPKs: function, regulation, role in cancer and therapeutic targeting DN Dhanasekaran, GL Johnson Oncogene 26 (22), 3097-3097, 2007 | 159 | 2007 |
Chemical sensing of DNT by engineered olfactory yeast strain V Radhika, T Proikas-Cezanne, M Jayaraman, D Onesime, JH Ha, ... Nature chemical biology 3 (6), 325-330, 2007 | 156 | 2007 |
Curcumin induces apoptosis by inhibiting sarco/endoplasmic reticulum Ca2+ ATPase activity in ovarian cancer cells J Seo, B Kim, DN Dhanasekaran, BK Tsang, YS Song Cancer letters 371 (1), 30-37, 2016 | 136 | 2016 |
Molecular and serum markers in hepatocellular carcinoma: predictive tools for prognosis and recurrence A Singhal, M Jayaraman, DN Dhanasekaran, V Kohli Critical reviews in oncology/hematology 82 (2), 116-140, 2012 | 123 | 2012 |
MICU1 drives glycolysis and chemoresistance in ovarian cancer PK Chakraborty, SB Mustafi, X Xiong, SKD Dwivedi, V Nesin, S Saha, ... Nature communications 8 (1), 14634, 2017 | 121 | 2017 |
Mitochondrial fission causes cisplatin resistance under hypoxic conditions via ROS in ovarian cancer cells Y Han, B Kim, U Cho, IS Park, SI Kim, DN Dhanasekaran, BK Tsang, ... Oncogene 38 (45), 7089-7105, 2019 | 117 | 2019 |
Exploitation of exosomes as nanocarriers for gene-, chemo-, and immune-therapy of cancer A Srivastava, A Babu, J Filant, KM Moxley, R Ruskin, D Dhanasekaran, ... Journal of biomedical nanotechnology 12 (6), 1159-1173, 2016 | 97 | 2016 |
A non-invasive liquid biopsy screening of urine-derived exosomes for miRNAs as biomarkers in endometrial cancer patients A Srivastava, K Moxley, R Ruskin, DN Dhanasekaran, YD Zhao, ... The AAPS Journal 20, 1-11, 2018 | 85 | 2018 |
Regulation of platelet myosin light chain (MYL9) by RUNX1: implications for thrombocytopenia and platelet dysfunction in RUNX1 haplodeficiency G Jalagadugula, G Mao, G Kaur, LE Goldfinger, DN Dhanasekaran, ... Blood, The Journal of the American Society of Hematology 116 (26), 6037-6045, 2010 | 84 | 2010 |
Dietary vitamin and lipid therapy rescues aberrant signaling and apoptosis and prevents hyperglycemia-induced diabetic embryopathy in rats EA Reece, YK Wu, Z Zhao, D Dhanasekaran American journal of obstetrics and gynecology 194 (2), 580-585, 2006 | 82 | 2006 |
Resveratrol triggers ER stress-mediated apoptosis by disrupting N-linked glycosylation of proteins in ovarian cancer cells HR Gwak, S Kim, DN Dhanasekaran, YS Song Cancer letters 371 (2), 347-353, 2016 | 80 | 2016 |
Ovarian cancer cell-derived lysophosphatidic acid induces glycolytic shift and cancer-associated fibroblast-phenotype in normal and peritumoral fibroblasts R Radhakrishnan, JH Ha, M Jayaraman, J Liu, KM Moxley, C Isidoro, ... Cancer letters 442, 464-474, 2019 | 74 | 2019 |
Resveratrol as a tumor-suppressive nutraceutical modulating tumor microenvironment and malignant behaviors of cancer Y Han, HA Jo, JH Cho, DN Dhanasekaran, YS Song International journal of molecular sciences 20 (4), 925, 2019 | 73 | 2019 |
LPA induces metabolic reprogramming in ovarian cancer via a pseudohypoxic response JH Ha, R Radhakrishnan, M Jayaraman, M Yan, JD Ward, KM Fung, ... Cancer research 78 (8), 1923-1934, 2018 | 71 | 2018 |
Metformin induces degradation of cyclin D1 via AMPK/GSK3β axis in ovarian cancer HR Gwak, Y Kim, H An, DN Dhanasekaran, YS Song Molecular carcinogenesis 56 (2), 349-358, 2017 | 70 | 2017 |
Role of m1 receptor-G protein coupling in cell proliferation in the prostate GR Luthin, P Wang, H Zhou, D Dhanasekaran, MR Ruggieri Life sciences 60 (13-14), 963-968, 1997 | 70 | 1997 |